Sentence: This was confirmed and show that the dCK levels are retained upon co-treatment , indicating a clinical use for bortezomib treatment in combination with cytarabine to avoid development of resistance .
Drug combination annotation:
[{'class': 'POS', 'spans': ['bortezomib', 'cytarabine'], 'is_context_needed': False}]